NEW YORK–(BUSINESS WIRE)–Doctors in the US, UK, and 5 EU nations estimate that on average 36% of their patients are COVID-19 vaccine hesitant, says SurveyHealthcareGlobus data
Author: Business Wire
2020 Study of the U.S Multifocal Contact Lens Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “2020 Study of the U.S Multifocal Contact Lens Market” report has been added to ResearchAndMarkets.com’s offering. Interest in contact lenses for multifocal correction has been increasing among adults 40 and older who requi…
NovaBay Pharmaceuticals Expands Avenova® Consumer Marketing through Affiliate Programs and Enhanced Lifestyle Public Relations
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces expanded Avenova® consumer marketing programs designed to generate greater awareness of its antimicrobial lid and lash spray and promote online sales. No…
Aerie Pharmaceuticals Announces Successful Interim 90-Day Topline Data From Its Six-Month Mercury 3 Clinical Trial in Europe
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Ophthalmology Devices Market 2020-2024: Forecasting Strategy to Undergo A Paradigm Shift from Crisis to New Normal during COVID-19 Pandemic
LONDON–(BUSINESS WIRE)– #GlobalOphthalmologyDevicesMarket–The Global Ophthalmology Devices Market will grow by USD 13.03 bn during 2020-2024
Contact Lenses Market – Global Outlook and Forecast 2020-2025: Market has Observed a Decline of Approx $1,409.62 Million Due to COVID-19 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market – Global Outlook and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering. The contact lenses market by revenue is expected to grow at a CAGR of over 5% during the period 201…
Haymarket Medical Network Launches Ophthalmology Advisor
NEW YORK–(BUSINESS WIRE)– #haymarket–Haymarket Medical Network today launched Ophthalmology Advisor, a new digital resource that empowers ophthalmology healthcare professionals with comprehensive clinical, surgical, and pharmaceutical information. O…
Solutionreach Adds Automated Answering Service from MedXCom to Marketplace
LEHI, Utah–(BUSINESS WIRE)– #Healthcare–Solutionreach, the leader in patient relationship management (PRM) solutions, announced today it has partnered with MedXCom to offer a reliable, HIPAA-compliant answering service solution for medical, dental a…
Second Sight Medical Products Inc. Announces Resumption of Its Early Feasibility Study of the Orion® Cortical Visual Prosthesis at UCLA
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today annou…
Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration
LONDON–(BUSINESS WIRE)– #GeneTherapy–Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration.
Worldwide Dry Eye Disease Diagnostics & Treatment Industry to 2030 – Major Drivers, Restraints, Opportunities & Threats – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Disease Diagnostics & Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The publisher’s report on the…
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to a new employee as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with…
Global Contact Lenses Market Trajectory & Analytics Report 2020-2027: Aesthetics and Improving Functionality Steer Growth Opportunities for the $15.7 Billion Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Contact Lenses Market to Reach US$15.7 Billion by 2027 The global contact lenses market is proje…
Global Electro Optical Systems Market Analysis 2020-2027: How Supply Chain Opportunities Are Changing in the High-Tech Industry Amid the Pandemic – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Electro Optical Systems – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. A pandemic of unprecedented proportions in terms of scale and speed, COVID-19 is creating a mi…
MetLife to Acquire Versant Health, Owner of Davis Vision and Superior Vision
NEW YORK–(BUSINESS WIRE)–METLIFE TO ACQUIRE VERSANT HEALTH, OWNER OF DAVIS VISION AND SUPERIOR VISION
Global Eyewear Market- Featuring Bausch Health Companies Inc, Carl Zeiss AG, and De Rigo Vision Spa Among Others
LONDON–(BUSINESS WIRE)– #EyewearMarket–The Global Eyewear Market will grow by USD 57.69 bn during 2020-2024
ProtoKinetix AAGP® Restores Vision in Blind Test Subjects
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Restores Vision in Blind Test Subjects
Aviceda Therapeutics Appoints Biopharma and Business Veterans Chris Adams, PhD, MBA, and Nancy K. Thomason, MBA to its Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics is a pre-clinical stage biotech company focused on the next generation of glycol-immune therapeutics utilizing the Glyco-Code technology to address the innate immune system and chronic non-resolvi…
Guide Dogs for the Blind Partners With Be My Eyes to Give Real-Time Video Assistance to Alumni via Innovative App
SAN RAFAEL, Calif.–(BUSINESS WIRE)– #BeMyEyesApp–Guide Dogs for the Blind partnered with Be My Eyes, an innovative app, that provides real-time video assistance to people who are visually impaired.
Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval of its Athlone, Ireland Facility for Production of Rhopressa® (netarsudil ophthalmic solution) 0.02%
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…